je.st
news
Novavax: Early study indicates its vaccine effective vs. RSV
2015-08-11 03:06:09| Biotech - Topix.net
Early research in older adults found an experimental vaccine prevented nearly two-thirds of serious cases of a common, seasonal respiratory virus that annually kills thousands of vulnerable Americans - babies and senior citizens. If further testing by vaccine developer Novavax Inc. goes well, in a few years the biotech company's genetically engineered shot could become the first vaccine approved against respiratory syncytial virus, or RSV.
Tags: study
early
effective
vs
Category:Biotechnology and Pharmaceuticals